Drug Shortage Report for SANDOZ HYDROCORTISONE
Report ID | 116932 |
Drug Identification Number | 02469421 |
Brand name | SANDOZ HYDROCORTISONE |
Common or Proper name | SANDOZ HYDROCORTISONE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCORTISONE |
Strength(s) | 2.5% |
Dosage form(s) | CREAM |
Route of administration | TOPICAL TOPICAL |
Packaging size | 45 G TU |
ATC code | D07AA |
ATC description | CORTICOSTEROIDS, PLAIN |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2020-06-05 |
Estimated end date | 2020-06-19 |
Actual end date | 2020-06-12 |
Shortage status | Resolved |
Updated date | 2020-06-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-06-15 | French | Compare |
v3 | 2020-06-15 | English | Compare |
v2 | 2020-06-08 | French | Compare |
v1 | 2020-06-08 | English | Compare |
Showing 1 to 4 of 4